Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.89% | $1.89M | €435.69B | 61.23% | 76 Outperform | |
| HSBC Holdings | 2.28% | $1.49M | £224.58B | 50.66% | 80 Outperform | |
| Roche Holding AG | 1.94% | $1.27M | CHF287.79B | 44.17% | 73 Outperform | |
| British American Tobacco | 1.64% | $1.07M | £97.50B | 36.79% | 71 Outperform | |
| Siemens | 1.57% | $1.03M | €188.82B | 17.68% | 74 Outperform | |
| Banco Bilbao Vizcaya Argentaria | 1.34% | $875.40K | €124.77B | 73.39% | 76 Outperform | |
| Novartis AG | 1.32% | $859.11K | CHF225.91B | 22.08% | 80 Outperform | |
| Mizuho Financial Group | 1.29% | $842.61K | ¥18.02T | 70.10% | 77 Outperform | |
| AstraZeneca | 1.28% | $836.40K | £213.91B | 28.21% | 80 Outperform | |
| Shell (UK) | 1.28% | $833.01K | £162.36B | 4.65% | 73 Outperform |